80 related articles for article (PubMed ID: 17729334)
1. MRI measurements of tumor size and pharmacokinetic parameters as early predictors of response in breast cancer patients undergoing neoadjuvant anthracycline chemotherapy.
Yu HJ; Chen JH; Mehta RS; Nalcioglu O; Su MY
J Magn Reson Imaging; 2007 Sep; 26(3):615-23. PubMed ID: 17729334
[TBL] [Abstract][Full Text] [Related]
2. Multi-parametric MRI in the early prediction of response to neo-adjuvant chemotherapy in breast cancer: Value of non-modelled parameters.
O'Flynn EA; Collins D; D'Arcy J; Schmidt M; de Souza NM
Eur J Radiol; 2016 Apr; 85(4):837-42. PubMed ID: 26971432
[TBL] [Abstract][Full Text] [Related]
3. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) for pretreatment prediction of neoadjuvant chemotherapy response in locally advanced hypopharyngeal cancer.
Guo W; Zhang Y; Luo D; Yuan H
Br J Radiol; 2020 Nov; 93(1115):20200751. PubMed ID: 32915647
[No Abstract] [Full Text] [Related]
4. Comparing the Performances of Magnetic Resonance Imaging Size vs Pharmacokinetic Parameters to Predict Response to Neoadjuvant Chemotherapy and Survival in Patients With Breast Cancer.
Dogan BE; Yuan Q; Bassett R; Guvenc I; Jackson EF; Cristofanilli M; Whitman GJ
Curr Probl Diagn Radiol; 2019; 48(3):235-240. PubMed ID: 29685400
[TBL] [Abstract][Full Text] [Related]
5. [Texture analysis based on contrast-enhanced MRI can predict treatment response to neoadjuvant chemotherapy of breast cancer].
Sun SH; Zhou CW; Zhao LY; Zhang RZ; Ouyang H
Zhonghua Zhong Liu Za Zhi; 2017 May; 39(5):344-349. PubMed ID: 28535650
[No Abstract] [Full Text] [Related]
6. Predicting Neoadjuvant Chemotherapy in Nonconcentric Shrinkage Pattern of Breast Cancer Using 1H-Magnetic Resonance Spectroscopic Imaging.
Zhou J; Qiao PG; Zhang HT; Li GJ; Jiang ZF
J Comput Assist Tomogr; 2018; 42(1):12-18. PubMed ID: 28708720
[TBL] [Abstract][Full Text] [Related]
7. A nomogram for predicting pathological complete response in patients with human epidermal growth factor receptor 2 negative breast cancer.
Jin X; Jiang YZ; Chen S; Yu KD; Ma D; Sun W; Shao ZM; Di GH
BMC Cancer; 2016 Aug; 16():606. PubMed ID: 27495967
[TBL] [Abstract][Full Text] [Related]
8. [Diagnostic value of quantitative pharmacokinetic parameters and relative quantitative pharmacokinetic parameters in breast lesions with dynamic contrast-enhanced MRI].
Sun TT; Liu WH; Zhang YQ; Li LH; Wang R; Ye YY
Zhonghua Yi Xue Za Zhi; 2017 Aug; 97(29):2266-2270. PubMed ID: 28780840
[No Abstract] [Full Text] [Related]
9. Tumor texture parameters of invasive ductal breast carcinoma in neoadjuvant chemotherapy: early identification of non-responders on breast MRI.
Nadrljanski MM; Milosevic ZC
Clin Imaging; 2020 Sep; 65():119-123. PubMed ID: 32446129
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous PET/MRI assessment of response to cytotoxic and hormone neo-adjuvant chemotherapy in breast cancer: a preliminary report.
Romeo V; D'Aiuto M; Frasci G; Imbriaco M; Nicolai E
Med Oncol; 2017 Feb; 34(2):18. PubMed ID: 28035580
[TBL] [Abstract][Full Text] [Related]
11. Prediction of neoadjuvant chemotherapy response using diffuse optical spectroscopy in breast cancer.
Yu YH; Zhu X; Mo QG; Cui Y
Clin Transl Oncol; 2018 Apr; 20(4):524-533. PubMed ID: 28921461
[TBL] [Abstract][Full Text] [Related]
12. Hyperpolarized
Woitek R; McLean MA; Gill AB; Grist JT; Provenzano E; Patterson AJ; Ursprung S; Torheim T; Zaccagna F; Locke M; Laurent MC; Hilborne S; Frary A; Beer L; Rundo L; Patterson I; Slough R; Kane J; Biggs H; Harrison E; Lanz T; Basu B; Baird R; Sala E; Graves MJ; Gilbert FJ; Abraham JE; Caldas C; Brindle KM; Gallagher FA
Radiol Imaging Cancer; 2020 Jul; 2(4):e200017. PubMed ID: 32803167
[TBL] [Abstract][Full Text] [Related]
13. [Application of decision curve on evaluation of MRI predictive model for early assessing pathological complete response to neoadjuvant therapy in breast cancer].
He YJ; Li XT; Fan ZQ; Li YL; Cao K; Sun YS; Ouyang T
Zhonghua Yi Xue Za Zhi; 2018 Jan; 98(4):260-263. PubMed ID: 29397610
[No Abstract] [Full Text] [Related]
14. Prospective early response imaging biomarker for neoadjuvant breast cancer chemotherapy.
Lee KC; Moffat BA; Schott AF; Layman R; Ellingworth S; Juliar R; Khan AP; Helvie M; Meyer CR; Chenevert TL; Rehemtulla A; Ross BD
Clin Cancer Res; 2007 Jan; 13(2 Pt 1):443-50. PubMed ID: 17255264
[TBL] [Abstract][Full Text] [Related]
15. A mechanically coupled reaction-diffusion model for predicting the response of breast tumors to neoadjuvant chemotherapy.
Weis JA; Miga MI; Arlinghaus LR; Li X; Chakravarthy AB; Abramson V; Farley J; Yankeelov TE
Phys Med Biol; 2013 Sep; 58(17):5851-66. PubMed ID: 23920113
[TBL] [Abstract][Full Text] [Related]
16. Early prediction of pathologic response to neoadjuvant therapy in breast cancer: systematic review of the accuracy of MRI.
Marinovich ML; Sardanelli F; Ciatto S; Mamounas E; Brennan M; Macaskill P; Irwig L; von Minckwitz G; Houssami N
Breast; 2012 Oct; 21(5):669-77. PubMed ID: 22863284
[TBL] [Abstract][Full Text] [Related]
17. Use of dynamic contrast-enhanced MR imaging to predict survival in patients with primary breast cancer undergoing neoadjuvant chemotherapy.
Li SP; Makris A; Beresford MJ; Taylor NJ; Ah-See ML; Stirling JJ; d'Arcy JA; Collins DJ; Kozarski R; Padhani AR
Radiology; 2011 Jul; 260(1):68-78. PubMed ID: 21502383
[TBL] [Abstract][Full Text] [Related]
18. Early changes in functional dynamic magnetic resonance imaging predict for pathologic response to neoadjuvant chemotherapy in primary breast cancer.
Ah-See ML; Makris A; Taylor NJ; Harrison M; Richman PI; Burcombe RJ; Stirling JJ; d'Arcy JA; Collins DJ; Pittam MR; Ravichandran D; Padhani AR
Clin Cancer Res; 2008 Oct; 14(20):6580-9. PubMed ID: 18927299
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of pre-treatment DCE-MRI parameters in predicting disease free and overall survival for breast cancer patients undergoing neoadjuvant chemotherapy.
Pickles MD; Manton DJ; Lowry M; Turnbull LW
Eur J Radiol; 2009 Sep; 71(3):498-505. PubMed ID: 18572340
[TBL] [Abstract][Full Text] [Related]
20. Staging Breast Cancer with MRI, the T. A Key Role in the Neoadjuvant Setting.
Panico C; Ferrara F; Woitek R; D'Angelo A; Di Paola V; Bufi E; Conti M; Palma S; Cicero SL; Cimino G; Belli P; Manfredi R
Cancers (Basel); 2022 Nov; 14(23):. PubMed ID: 36497265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
